Ikena Oncology, Inc. IKNA
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| Blue Owl Capital Holdings LP | 4091118 | 0 | 4091118 | 0 | 4091118 | 8.48 % | 14/11/2024 | |
| Gilead Sciences, Inc. | Delaware | 2931467 | 0 | 2931467 | 0 | 2931467 | 6.7 % | 19/10/2023 |
| Omega Fund VI GP Manager, Ltd. | 0 | 2249123 | 0 | 2249123 | 2249123 | 6.3 % | 14/02/2022 | |
| Otello Stampacchia | 0 | 2249123 | 0 | 2249123 | 2249123 | 6.3 % | 14/02/2022 | |
| Anne-Mari Paster | 0 | 2249123 | 0 | 2249123 | 2249123 | 6.3 % | 14/02/2022 | |
| Omega Fund VI, L.P. | 0 | 2249123 | 0 | 2249123 | 2249123 | 6.3 % | 14/02/2022 | |
| Claudio Nessi | 0 | 2249123 | 0 | 2249123 | 2249123 | 6.3 % | 14/02/2022 | |
| Omega Fund VI GP, L.P. | 0 | 2249123 | 0 | 2249123 | 2249123 | 6.3 % | 14/02/2022 | |
| I, LLC | Delaware | 0 | 874634 | 0 | 10 | 874634 | 2.4 % | 11/02/2022 |
| LLC | Delaware | 0 | 1241935 | 0 | 10 | 1241935 | 3.5 % | 11/02/2022 |
| ATLAS VENTURE FUND X, L.P. | Delaware | 0 | 2901609 | 0 | 10 | 2901609 | 8.1 % | 11/02/2022 |
| ATLAS VENTURE ASSOCIATES X, L.P. | Delaware | 0 | 2901609 | 0 | 10 | 2901609 | 8.1 % | 11/02/2022 |
| LLC | Delaware | 0 | 2901609 | 0 | 10 | 2901609 | 8.1 % | 11/02/2022 |
| ATLAS VENTURE FUND XI, L.P. | Delaware | 0 | 1241935 | 0 | 10 | 1241935 | 3.5 % | 11/02/2022 |
| ATLAS VENTURE ASSOCIATES XI, L.P. | Delaware | 0 | 1241935 | 0 | 10 | 1241935 | 3.5 % | 11/02/2022 |
| I, L.P. | Delaware | 0 | 874634 | 0 | 10 | 874634 | 2.4 % | 11/02/2022 |
| I, L.P. | Delaware | 0 | 874634 | 0 | 10 | 874634 | 2.4 % | 11/02/2022 |
| OrbiMed Advisors LLC | Delaware | 0 | 1936886 | 0 | 10 | 1936886 | 6.56 % | 14/04/2021 |
| OrbiMed Capital LLC | Cayman Islands | 997055 | 0 | 997055 | 10 | 997055 | 3.37 % | 14/04/2021 |
| OrbiMed Genesis GP LLC | Delaware | 0 | 91014 | 0 | 10 | 91014 | 0.31 % | 14/04/2021 |
| OrbiMed Capital GP VI LLC | Delaware | 0 | 1845872 | 0 | 10 | 1845872 | 6.25 % | 14/04/2021 |
| Abigail P. Johnson | United States of America | 0 | 0 | 3777638 | 0 | 3777638 | 12.541 % | 12/04/2021 |
| FMR LLC | Delaware | 254800 | 0 | 3777638 | 0 | 3777638 | 12.541 % | 12/04/2021 |
| 2. | Delaware | 0 | 2053068 | 0 | 0 | 10 | 6.6 % | 09/04/2021 |
| 2. | Delaware | 0 | 2054953 | 0 | 0 | 10 | 6.6 % | 09/04/2021 |
| 2. | Delaware | 0 | 2053068 | 0 | 0 | 10 | 6.6 % | 09/04/2021 |
| 2. | Delaware | 0 | 2053068 | 0 | 0 | 10 | 6.6 % | 09/04/2021 |
| 2. | Delaware | 0 | 1885 | 0 | 0 | 10 | 12 % | 09/04/2021 |
| 2. | Delaware | 0 | 1885 | 0 | 0 | 10 | 12 % | 09/04/2021 |
| 2. | Delaware | 0 | 1885 | 0 | 0 | 10 | 12 % | 09/04/2021 |
| BRISTOL-MYERS SQUIBB COMPANY 22-0790350 | Delaware, U.S.A. | 0 | 2133142 | 0 | 2133142 | 2133142 | 5.9 % | 05/04/2021 |
| CELGENE CORPORATION 22-2711928 | Delaware, U.S.A. | 0 | 2133142 | 0 | 2133142 | 2133142 | 5.9 % | 05/04/2021 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 102743 | 102743 | 1 % | 05/04/2021 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 853138 | 853138 | 2.7 % | 05/04/2021 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 633705 | 633705 | 2 % | 05/04/2021 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 633705 | 633705 | 2 % | 05/04/2021 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 0 | 0 | 1486843 | 1486843 | 4.8 % | 05/04/2021 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 1599658 | 1599658 | 5.1 % | 05/04/2021 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 1599658 | 1599658 | 5.1 % | 05/04/2021 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 853138 | 853138 | 2.7 % | 05/04/2021 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 1599658 | 1599658 | 5.1 % | 05/04/2021 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 102743 | 102743 | 1 % | 05/04/2021 |